GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Beginning Cash Position

Statera BioPharma (STU:7CB) Beginning Cash Position : €0.56 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Beginning Cash Position?

Statera BioPharma's Beginning Cash Position for the quarter that ended in Sep. 2022 was €0.56 Mil.

Statera BioPharma's quarterly Beginning Cash Position declined from Mar. 2022 (€6.21 Mil) to Jun. 2022 (€0.15 Mil) but then increased from Jun. 2022 (€0.15 Mil) to Sep. 2022 (€0.56 Mil).

Statera BioPharma's annual Beginning Cash Position declined from Dec. 2019 (€0.01 Mil) to Dec. 2020 (€0.00 Mil) but then increased from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.53 Mil).


Statera BioPharma Beginning Cash Position Historical Data

The historical data trend for Statera BioPharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Beginning Cash Position Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Beginning Cash Position
0.01 - 0.53

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 13.36 12.58 6.21 0.15 0.56

Statera BioPharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Statera BioPharma Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma Headlines

No Headlines